0001753926-20-000030.txt : 20200303 0001753926-20-000030.hdr.sgml : 20200303 20200303095222 ACCESSION NUMBER: 0001753926-20-000030 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200303 DATE AS OF CHANGE: 20200303 EFFECTIVENESS DATE: 20200303 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Aspargo Laboratories, Inc. CENTRAL INDEX KEY: 0001805092 IRS NUMBER: 843757833 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-361806 FILM NUMBER: 20680305 BUSINESS ADDRESS: STREET 1: 550 SYLVAN AVENUE, SUITE 102 CITY: ENGLEWOOD CLIFFS STATE: NJ ZIP: 07632 BUSINESS PHONE: 201-408-4831 MAIL ADDRESS: STREET 1: 550 SYLVAN AVENUE, SUITE 102 CITY: ENGLEWOOD CLIFFS STATE: NJ ZIP: 07632 D 1 primary_doc.xml X0708 D LIVE 0001805092 Aspargo Laboratories, Inc. 550 SYLVAN AVENUE, SUITE 102 ENGLEWOOD CLIFFS NJ NEW JERSEY 07632 201-408-4831 DELAWARE VirgaTech, Inc. None Corporation true 2019 Michael Demurjian 610 Hubbard Avenue Red Bank NJ NEW JERSEY 07701 Executive Officer Director Michael Rice 155 Walnut St. Englewood NJ NEW JERSEY 07631 Director Fred Biehl 75 Eisenhower Parkway Roseland NJ NEW JERSEY 07068 Director Pharmaceuticals No Revenues 06b false 2020-02-05 false true false 10000 8500000 235000 8265000 false 6 0 0 0 The company is virtual. All executives are acting as consultants without cash compensation. false Aspargo Laboratories, Inc. /s/ Michael Demurjian Michael Demurjian CEO 2020-03-03